Loading...
Loading...
Hapoalim Securities is terminating coverage of Bristol-Myers
BMY, Eli Lilly
LLY, Merck
MRK, Pfizer
PFE, Acorda
ACOR, Alkermes
ALKS, Amarin
AMRN, Amylin
AMLN, Arena Pharmaceuticals
ARNA, Auxilium
AUXL, Biospecifics
BSTC, Cephalon
CEPH, MannKind
MNKD, Medivation
MDVN, Nektar
NKTR, Neurocrine Biosciences
NBIX, Protalix
PLX, Targacept
TRGT and Vanda Pharmaceuticals
VNDA due to an analyst departure.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In: Analyst RatingsBiotechnologyHapoalim SecuritiesHealth CareLife Sciences Tools & ServicesPharmaceuticals
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
